share print

Women's health pipeline

As part of our continuous pursuit of excellence and in our continual efforts to drive innovation in the area of women’s health, we actively invest in the development of new products.

OC-OTC (Oral Contraceptives - Over-the-Counter)

Increased access to reproductive healthcare and improvements in women’s ability to access safe and effective contraceptive methods are key elements of our company’s commitment since its inception.

HRA Pharma is partnering with advocates and experts from Ibis Reproductive Health, an international non-profit research organisation for reproductive health, to start the process of bringing an over-the-counter oral contraceptive to the US market.

Oral contraceptives are some of the best-studied medicines on the market today (1) and enjoy longstanding support from medical and public health experts. OTC oral contraceptives would represent an important advancement and complement to other strategies aimed at enhancing women’s access to the full range of contraceptive methods.

1 - Daniel Grossman, Over-the-counter access to oral contraceptives. Expert Review of Obstetrics & Gynecology 501-508, Vol 6, 11 - Issue 5

closeyou are leaving hra pharma
You are now leaving and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?